IRIS Institutional Research Information System - OPENBS Open Archive UniBS

LAGANÀ, MARTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.064
AS - Asia 2.055
EU - Europa 1.612
SA - Sud America 310
AF - Africa 44
OC - Oceania 4
Totale 7.089
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.973
SG - Singapore 792
IT - Italia 491
CN - Cina 464
BR - Brasile 252
PL - Polonia 250
BD - Bangladesh 225
FI - Finlandia 200
HK - Hong Kong 187
VN - Vietnam 169
DE - Germania 161
GB - Regno Unito 93
FR - Francia 73
IE - Irlanda 61
TR - Turchia 60
RU - Federazione Russa 57
UA - Ucraina 56
CA - Canada 50
IN - India 41
SE - Svezia 34
NL - Olanda 32
ID - Indonesia 26
MX - Messico 24
AR - Argentina 21
CZ - Repubblica Ceca 18
ZA - Sudafrica 17
ES - Italia 15
BE - Belgio 14
IQ - Iraq 14
JP - Giappone 14
AT - Austria 10
CH - Svizzera 10
EC - Ecuador 10
DZ - Algeria 8
PH - Filippine 8
PK - Pakistan 8
CL - Cile 7
LT - Lituania 7
MA - Marocco 7
SA - Arabia Saudita 7
PT - Portogallo 6
BG - Bulgaria 5
CO - Colombia 5
CR - Costa Rica 5
UZ - Uzbekistan 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
LB - Libano 4
RO - Romania 4
AU - Australia 3
ET - Etiopia 3
HN - Honduras 3
JM - Giamaica 3
JO - Giordania 3
KE - Kenya 3
LV - Lettonia 3
NP - Nepal 3
OM - Oman 3
PY - Paraguay 3
AZ - Azerbaigian 2
CY - Cipro 2
GY - Guiana 2
KZ - Kazakistan 2
MD - Moldavia 2
MK - Macedonia 2
MY - Malesia 2
PE - Perù 2
RS - Serbia 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
ZW - Zimbabwe 2
AO - Angola 1
BB - Barbados 1
BO - Bolivia 1
EE - Estonia 1
GT - Guatemala 1
HU - Ungheria 1
IR - Iran 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
MU - Mauritius 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TG - Togo 1
Totale 7.089
Salva come PNG Salva come JPEG
Città #
Singapore 428
Ashburn 325
San Jose 288
Dallas 246
Warsaw 246
Hong Kong 187
Helsinki 148
New York 146
Los Angeles 123
Fairfield 121
Beijing 110
Chandler 92
The Dalles 79
Chicago 75
Munich 62
Council Bluffs 61
Milan 55
Ho Chi Minh City 54
Seattle 54
Wilmington 53
Brescia 50
Istanbul 46
Lauterbourg 46
Houston 45
Princeton 45
Woodbridge 43
Buffalo 42
Dalmine 39
Cambridge 38
Jacksonville 38
Boardman 36
Turku 35
Santa Clara 34
Redondo Beach 30
Secaucus 30
Hanoi 29
Rome 28
Dublin 27
Moscow 26
Shanghai 26
Jakarta 25
Dong Ket 24
Salt Lake City 24
Orem 23
Menlo Park 22
San Francisco 22
London 21
Naples 21
São Paulo 20
West Jordan 20
Bergamo 19
Des Moines 19
Poplar 18
Nuremberg 17
Ann Arbor 16
Lappeenranta 16
Brno 15
Stockholm 15
Brussels 14
Elk Grove Village 14
Rio de Janeiro 14
Atlanta 13
Boston 13
Brooklyn 13
Johannesburg 13
Phoenix 13
Toronto 13
Montreal 12
Amsterdam 11
Frankfurt am Main 11
Romola 11
Tampa 11
Pune 10
Tokyo 10
Manchester 9
Turin 9
Biên Hòa 8
Chennai 8
Da Nang 8
Denver 8
Paris 8
San Diego 8
Tianjin 8
Bari 7
Brasília 7
Charlotte 7
Dulles 7
Düsseldorf 7
New Delhi 7
Ankara 6
Curitiba 6
Dearborn 6
Dhaka 6
Guangzhou 6
Las Vegas 6
Livorno 6
Mumbai 6
Raleigh 6
Sterling 6
São Bernardo do Campo 6
Totale 4.421
Salva come PNG Salva come JPEG
Nome #
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 381
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 256
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 228
Immunotherapy failure in adrenocortical cancer: where next? 223
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 199
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 189
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 184
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 182
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines? 173
Correction: Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 148
Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case report 148
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 147
Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma 138
Gastrointestinal Toxicity of Antibody Drug Conjugates (ADCs) in Metastatic Breast Cancer: A Pooled Analysis 136
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 132
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 132
Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study. 129
High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases 129
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer 127
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 126
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 125
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 125
Oncological treatment administration at end of life: a retrospective study 124
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 122
Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study 118
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 117
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 116
Changes in body composition in early breast cancer patients treated with aromatase inhibitors 116
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy 112
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 111
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status 110
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis 108
Is weight gain preventable in women with early breast cancer undergoing chemotherapy? A real-world study on dietary pattern, physical activity, and body weight before and after chemotherapy 106
The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma 105
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study 101
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 100
Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter? 100
Letter to the editor from Berruti et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival" 98
Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies 98
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma 94
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy 93
Adjuvant denosumab for early breast cancer-Evidence and controversy 86
The Value of Local Therapies in Advanced Adrenocortical Carcinoma 85
The Evolving Treatment Landscape of Medullary Thyroid Cancer 83
Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy 82
Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients 82
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study 75
Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma 71
Total and Regional Changes in Body Composition in Metastatic Hormone-sensitive Prostate Cancer Patients Randomized to Receive Androgen Deprivation + Enzalutamide ± Zoledronic Acid. The BONENZA Study 71
FGF/FGFR inhibitors downmodulates c-Myc oncoprotein and hampers the growth of adrenocortical carcinoma 61
New findings on presentation and outcome of patients with adrenocortical cancer: results from a national cohort study 56
Cardiovascular and metabolic comorbidities in patients with thyroid nodules: the impact of incidental diagnosis 56
Ambient air pollution and survival in SCLC/LCNEC: Analysis of a single centre retrospective cohort 52
null 51
Chemo-immunotherapy with cisplatin and nivolumab as second-line approach in metastatic adrenocortical carcinoma 50
Letter re: Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study 49
Oligometastatic adrenocortical carcinoma: definition and treatment 49
Prediction of fragility fractures in men with prostate cancer under androgen deprivation therapy: the importance of a multidisciplinary approach using a mini-invasive diagnostic tool 44
Venous thromboembolism in adrenocortical carcinoma: a retrospective analysis 43
Fragility fractures in well-differentiated gastroenteropancreatic neuroendocrine tumors: Results from a multicentered retrospective study 42
Case Report: Pathologic complete response in triple negative breast cancer treated with anthracycline free regimen 40
Predictors of survival outcomes in patients with neuroendocrine neoplasms: a real-world retrospective study 38
Prognostic role of pretreatment [18F]FDG PET/CT in patients affected by adrenocortical carcinoma and treated with chemotherapy 37
The role of 2-[18F]FDG PET/CT in adrenocortical carcinoma: a systematic review 31
Efficacy of RET inhibitors in the management of advanced, RET mutated, pheochromocytoma. Pooled analysis of published cases with the addition of 2 new cases 26
Quality of life questionnaire development and validation for adrenocortical carcinoma patients 22
Primary Adrenal Malignancies 12
Updating ACC preclinical models: characterization of two new patient-derived cell lines 6
Regional adrenalectomy completed by prophylactic hyperthermic intraperitoneal chemotherapy reduces the incidence of local and peritoneal recurrence after curative surgery for adrenocortical carcinoma 5
Multiparametric assessment of bone health in metastatic hormone-sensitive prostate cancer patients receiving androgen deprivation + enzalutamide ± zoledronic acid (BonEnza study) 5
Totale 7.216
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.396
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.396
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202143 0 0 0 0 0 0 0 0 0 0 0 43
2021/2022275 20 10 7 66 15 12 13 11 13 36 23 49
2022/2023249 31 16 18 15 19 51 4 27 26 8 17 17
2023/2024595 25 19 45 53 55 97 19 32 86 39 15 110
2024/20251.594 51 31 20 266 140 90 114 67 193 90 393 139
2025/20263.739 238 361 376 349 305 247 475 177 265 356 329 261
Totale 7.216